Planned delivery route of preterm breech singletons, and neonatal and 2-year outcomes: a population-based cohort study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Jan 2019
Historique:
accepted: 19 08 2018
pubmed: 15 9 2018
medline: 12 3 2019
entrez: 15 9 2018
Statut: ppublish

Résumé

To assess whether planned route of delivery is associated with perinatal and 2-year outcomes for preterm breech singletons. Prospective nationwide population-based EPIPAGE-2 cohort study. France, 2011. Three hundred and ninety women with breech singletons born at 26-34 weeks of gestation after preterm labour or preterm prelabour rupture of membranes. Propensity-score analysis. Survival at discharge, survival at discharge without severe morbidity, and survival at 2 years of corrected age without neurosensory impairment. Vaginal and caesarean deliveries were planned in 143 and 247 women, respectively. Neonates with planned vaginal delivery and planned caesarean delivery did not differ in survival (93.0 versus 95.7%, P = 0.14), survival at discharge without severe morbidity (90.4 versus 89.9%, P = 0.85), or survival at 2 years without neurosensory impairment (86.6 versus 91.6%, P = 0.11). After applying propensity scores and assigning inverse probability of treatment weighting, as compared with planned vaginal delivery, planned caesarean delivery was not associated with improved survival (odds ratio, OR 1.31; 95% confidence interval, 95% CI 0.67-2.59), survival without severe morbidity (OR 0.75, 95% CI 0.45-1.27), or survival at 2 years without neurosensory impairment (OR 1.04, 95% CI 0.60-1.80). Results were similar after matching on propensity score. No association between planned caesarean delivery and improved outcomes for preterm breech singletons born at 26-34 weeks of gestation after preterm labour or preterm prelabour rupture of membranes was found. The route of delivery should be discussed with women, balancing neonatal outcomes with the higher risks of maternal morbidity associated with caesarean section performed at low gestational age.

Identifiants

pubmed: 30216654
doi: 10.1111/1471-0528.15466
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-82

Subventions

Organisme : French Institute of Public Health Research/Institute of Public Health
Organisme : French Health Ministry
Organisme : National Institute of Health and Medical Research
Organisme : National Institute of Cancer
Organisme : National Solidarity Fund for Autonomy
Organisme : National Research Agency through the French EQUIPEX programme
ID : ANR-11-EQPX-0038
Organisme : PREMUP Foundation

Investigateurs

Pierre-Yves Ancel (PY)
Catherine Arnaud (C)
Julie Blanc (J)
Pascal Boileau (P)
Thierry Debillon (T)
Pierre Delorme (P)
Claude D'Ercole (C)
Thomas Desplanches (T)
Caroline Diguisto (C)
Laurence Foix-L'Hélias (L)
Aurélie Garbi (A)
Géraldine Gascoin (G)
Adrien Gaudineau (A)
Catherine Gire (C)
François Goffinet (F)
Gilles Kayem (G)
Bruno Langer (B)
Mathilde Letouzey (M)
Elsa Lorthe (E)
Emeline Maisonneuve (E)
Stéphane Marret (S)
Isabelle Monier (I)
Andrei Morgan (A)
Jean-Christophe Rozé (JC)
Thomas Schmitz (T)
Loïc Sentilhes (L)
Damien Subtil (D)
Héloïse Torchin (H)
Barthélémy Tosello (B)
Christophe Vayssière (C)
Norbert Winer (N)
Jennifer Zeitlin (J)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Royal College of Obstetricians and Gynaecologists.

Auteurs

E Lorthe (E)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.
EPIUnit - Institute of Public Health, University of Porto, Porto, Portugal.

L Sentilhes (L)

Department of Obstetrics and Gynaecology, Bordeaux University Hospital, Bordeaux, France.

M Quere (M)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.

C Lebeaux (C)

Reference Centre on Teratogenic Agents, Trousseau University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

N Winer (N)

Department of Obstetrics and Gynecology, CIC Mère Enfant, University Hospital, Nantes, France.
INRA, UMR 1280, Physiologie des adaptations nutritionnelles, Nantes, France.

H Torchin (H)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.
Neonatal Medicine and Resuscitation Service, Port-Royal, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.

F Goffinet (F)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.
Department of Obstetrics and Gynaecology, Cochin, Broca, Hôtel-Dieu, Assistance Publique - Hôpitaux de Paris, Paris, France.

P Delorme (P)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.
Department of Obstetrics and Gynaecology, Cochin, Broca, Hôtel-Dieu, Assistance Publique - Hôpitaux de Paris, Paris, France.

G Kayem (G)

Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.
Department of Obstetrics and Gynaecology, Trousseau University Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Universités, Université Pierre and Marie Curie Paris 06, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH